Arm Holdings filed a 6-K interim report with the SEC on 2026-08-10, likely containing quarterly financial results or a trading update for its fiscal quarter ending around June 2026 (FY2027 Q1). As a foreign private issuer listed on Nasdaq, Arm uses 6-K to furnish material periodic disclosures; this filing is relevant to PMs tracking AI/edge compute royalty growth, licensing revenue mix, and Armv9 adoption momentum. Full filing body not analyzed; description inferred from form type and filing date.
Vistra (VST) filed an 8-K disclosing quarterly earnings results (Item 2.02), with supporting exhibits (Item 9.01). As a major U.S. power generator with nuclear and gas assets increasingly tied to AI data-center electricity demand, VST earnings are a bellwether for power-sector capacity pricing and hyperscaler infrastructure cost trends — directly relevant to semiconductor capex sentiment. Full filing body not analyzed; description inferred from form + item codes.
Lam Research has filed its annual 10-K report for the fiscal year ended June 28, 2026, covering full-year financials, business segment performance, risk factors, and management outlook. Key PM focus areas include WFE spending trends, memory vs. logic equipment mix, China export control exposure, and any updated capital return guidance. Full filing body not analyzed; description inferred from form + item codes.
Microchip Technology filed its 10-Q for the quarter ended June 30, 2026, covering fiscal Q1 FY2027 results across its microcontroller, analog, and mixed-signal product lines. PMs will want to track revenue trajectory and gross-margin recovery as MCHP has been working through prolonged inventory digestion across industrial and automotive end markets. Full filing body not analyzed; description inferred from form + item codes.
KLA filed its annual 10-K for the fiscal year ended June 30, 2026, covering full-year financials, business conditions, risk factors, and MD&A. Full filing body not analyzed; description inferred from form + item codes. PMs should watch for revenue and margin trends amid ongoing WFE spending cycles, China exposure updates, and any changes to forward guidance or capital allocation.